Latest stories on MIRA
MIRA Pharmaceuticals announces positive preclinical results for MIRA-55
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Reports Positive Preclinical Data for SKNY-1 Program
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Advances Ketamir-2 Into FDA-Accepted Phase 2a Trial
TipRanks63 · neutralproduct/pr
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Appoints New Fractional Chief Financial Officer
TipRanks55 · neutralgeneral
MIRA PHARMACEUTICALS, INC. (MIRA) files 8-K
SEC 8-K50 · neutralgeneral
MIRA Pharmaceuticals Secures Unified Global Rights to Pipeline
TipRanks63 · neutralgeneral
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1 | MIRA Stock News
StockTitan67 · bullishproduct/pr
MIRA Expands Global Ketamir-2 License for Clinical Development
TipRanks59 · neutralproduct/pr